Why Choose a Site Network for Your Clinical Trials?

Background
Site selection can affect a study’s timeline, budget and data quality. The need to choose sites again for each new study is often time-consuming and inefficient. Moreover, the increase in the number of clinical trials as well as the different exclusion and inclusion criteria across trials have created challenges for selecting sites that perform well. Global site networks can effectively address these concerns, by providing access to multiple experienced sites within a single network, providing cost savings through reduction of the total number of sites used and recruitment of a large volume of patients.

What is a site network?
A clinical investigative site network is a group of clinical sites that are represented under one entity and chosen using specific criteria. These criteria can vary by the type of network that they are involved in but can include qualifications that are suited to conducting clinical trials in a consistent, standardized manner that results in high-quality data. With a site network, you have access to many sites through one central entity, including one point of contact for all site-related communications and for site feasibility assessments over the entire duration of the trial and multiple sites. This provides a more unified, holistic, simplified and efficient approach while streamlining communications, allowing the team to focus their attention on more important areas such as patient care and data quality. Furthermore, negotiations, contracts, budget and providers can be managed once, rather than for each site. Site networks also have the capacity to fill a large majority, if not all, the trial’s site requirements, depending on the therapeutic area and protocol.

Types of site networks
When selecting a site network for your clinical trials, it is important to recognize that not all site networks are the same. The available services within a site network can range from "broker" services, where different sites are contacted every time a new study is commenced, to full services, where the organization has control or ownership of the sites. The latter is key to ensuring that you consistently have access to qualified sites suited to your purpose. First, depending on therapeutic breadth and specialist availability new sites do not need to be found for every study; the same network of sites, with a proven track record, is available for consideration for each new study. Therefore, the site network can invest in key opinion leaders (KOLs), research professionals, project managers and outbound patient marketing to engage additional therapeutic experts, providing clients with access to the best research and researchers possible. The extensive resources available from the network help ensure uninterrupted service throughout the entire trial.

Often, these dedicated sites in a full-service site network are specialized centers in clinical research, which represents 100% of the work being conducted. As a result, the staff are experts at clinical research and are allocated specifically to conducting research, rather than dividing their time between research and their daily clinical duties related only to patient care. Patient care remains a priority at site network sites, and they are often able to better engage with the patient/partner/caregiver owing to their understanding of specific patient needs during clinical research.

Additional characteristics of optimal site networks 
Even within the available full-service site networks, there remain key differentiators. Understanding these can help with selecting the right fit for each study and realizing the inherent benefits of a site network: study completion with fewer sites, improved productivity, streamlined communication and cost savings.

With the increasing global nature of clinical trials, access to sites in other countries is likely to be of importance. The need for specific patient populations and the ability to follow the progress of a seasonal illness such as the flu is often only met by having access to investigative sites in a certain geographic location or on multiple continents. This is when it would be helpful to be able to tap into central global project management that has local regulatory knowledge, the ability to generate reports across all sites and resolve issues, when necessary. However, at the time of this whitepaper, the author is aware of only two site networks that provide global services.

Collecting data across multiple sites, even within the same country, introduces its own challenges for consistent and reliable data collection. To ensure data are collected in the same way at every site, a full-service site network would ideally have a standardized training program, in which all staff is trained to the same high-quality standards for their position and GCP/ICH. For example, all lab technicians would handle samples and data with the required oversight and level of quality. Furthermore, site coordinators should receive extensive training, and the same dedicated patient file, specifically developed for clinical research, should be used across all sites—to reduce entry errors and missing data.

Background
Site selection can affect a study’s timeline, budget and data quality. The need to choose sites again for each new study is often time-consuming and inefficient. Moreover, the increase in the number of clinical trials as well as the different exclusion and inclusion criteria across trials have created challenges for selecting sites that perform well. Global site networks can effectively address these concerns, by providing access to multiple experienced sites within a single network, providing cost savings through reduction of the total number of sites used and recruitment of a large volume of patients.

What is a site network?
A clinical investigative site network is a group of clinical sites that are represented under one entity and chosen using specific criteria. These criteria can vary by the type of network that they are involved in but can include qualifications that are suited to conducting clinical trials in a consistent, standardized manner that results in high-quality data. With a site network, you have access to many sites through one central entity, including one point of contact for all site-related communications and for site feasibility assessments over the entire duration of the trial and multiple sites. This provides a more unified, holistic, simplified and efficient approach while streamlining communications, allowing the team to focus their attention on more important areas such as patient care and data quality. Furthermore, negotiations, contracts, budget and providers can be managed once, rather than for each site. Site networks also have the capacity to fill a large majority, if not all, the trial’s site requirements, depending on the therapeutic area and protocol.

Types of site networks
When selecting a site network for your clinical trials, it is important to recognize that not all site networks are the same. The available services within a site network can range from "broker" services, where different sites are contacted every time a new study is commenced, to full services, where the organization has control or ownership of the sites. The latter is key to ensuring that you consistently have access to qualified sites suited to your purpose. First, depending on therapeutic breadth and specialist availability new sites do not need to be found for every study; the same network of sites, with a proven track record, is available for consideration for each new study. Therefore, the site network can invest in key opinion leaders (KOLs), research professionals, project managers and outbound patient marketing to engage additional therapeutic experts, providing clients with access to the best research and researchers possible. The extensive resources available from the network help ensure uninterrupted service throughout the entire trial.

Often, these dedicated sites in a full-service site network are specialized centers in clinical research, which represents 100% of the work being conducted. As a result, the staff are experts at clinical research and are allocated specifically to conducting research, rather than dividing their time between research and their daily clinical duties related only to patient care. Patient care remains a priority at site network sites, and they are often able to better engage with the patient/partner/caregiver owing to their understanding of specific patient needs during clinical research.

Additional characteristics of optimal site networks 
Even within the available full-service site networks, there remain key differentiators. Understanding these can help with selecting the right fit for each study and realizing the inherent benefits of a site network: study completion with fewer sites, improved productivity, streamlined communication and cost savings.

With the increasing global nature of clinical trials, access to sites in other countries is likely to be of importance. The need for specific patient populations and the ability to follow the progress of a seasonal illness such as the flu is often only met by having access to investigative sites in a certain geographic location or on multiple continents. This is when it would be helpful to be able to tap into central global project management that has local regulatory knowledge, the ability to generate reports across all sites and resolve issues, when necessary. However, at the time of this whitepaper, the author is aware of only two site networks that provide global services.

Collecting data across multiple sites, even within the same country, introduces its own challenges for consistent and reliable data collection. To ensure data are collected in the same way at every site, a full-service site network would ideally have a standardized training program, in which all staff is trained to the same high-quality standards for their position and GCP/ICH. For example, all lab technicians would handle samples and data with the required oversight and level of quality. Furthermore, site coordinators should receive extensive training, and the same dedicated patient file, specifically developed for clinical research, should be used across all sites—to reduce entry errors and missing data.

Register as Visitor to CPhI China 2018!